Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatol Baltim Md 2020;72:1605–1616. https://doi.org/10.1002/hep.31173.
Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2020;18:2650–2666. https://doi.org/10.1016/j.cgh.2019.07.060.
Singh AD, Mucha SR, Lindenmeyer CC. Cirrhotic coagulopathy: a rebalanced hemostasis. Cleve Clin J Med 2022;89:523–533. https://doi.org/10.3949/ccjm.89a.21018.
Ambrosino P, Tarantino L, Di Minno G et al. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost 2017;117:139–148. https://doi.org/10.1160/TH16-06-0450.
Subhani M, Sheth A, Ahmed J et al. Incidence and prevalence of venous thromboembolism in chronic liver disease: a systematic review and meta-analysis. Thromb Res 2022;215:19–29. https://doi.org/10.1016/j.thromres.2022.05.004.
Article CAS PubMed Google Scholar
Wu H, Nguyen GC. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2010;8:800–805. https://doi.org/10.1016/j.cgh.2010.05.014.
Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Hepatitis C virus infection and risk of venous thromboembolism: a systematic review and meta-analysis. Ann Hepatol 2017;16:514–520. https://doi.org/10.5604/01.3001.0010.0279.
Article CAS PubMed Google Scholar
Stine JG, Niccum BA, Zimmet AN et al. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to nonalcoholic steatohepatitis. Clin Transl Gastroenterol 2018;9:140. https://doi.org/10.1038/s41424-018-0002-y.
Article PubMed PubMed Central Google Scholar
Ng KJ, Lee YK, Huang MY, Hsu CY, Su YC. Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan. J Thromb Haemost 2015;13:206–213. https://doi.org/10.1111/jth.12805.
Jepsen P, Tapper EB, Deleuran T et al. Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a danish nation-wide cohort study. Hepatol Baltim Md 2021;74:2725–2734. https://doi.org/10.1002/hep.32019.
Bikdeli B, Jiménez D, Garcia-Tsao G et al. Venous Thromboembolism in patients with liver cirrhosis: findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry. Semin Thromb Hemost 2019;45:793–801. https://doi.org/10.1055/s-0039-1697682.
Søgaard KK, Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009;104:96–101. https://doi.org/10.1038/ajg.2008.34.
Molinari M, Fernandez-Carrillo C, Dai D et al. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transpl Int Off J Eur Soc Organ Transplant 2021;34:1105–1122. https://doi.org/10.1111/tri.13873.
Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 2015;21:1016–1021. https://doi.org/10.1002/lt.24134.
Ambrosino P, Tarantino L, Criscuolo L, Nasto A, Celentano A, Di Minno MND. The risk of venous thromboembolism in patients with hepatitis C. A systematic review and meta-analysis. Thromb Haemost 2016;116:958–966. https://doi.org/10.1160/TH16-03-0185.
NRD Overview. Accessed March 21, 2019. https://www.hcup-us.ahrq.gov/nrdoverview.jsp
Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020;3:e201997. https://doi.org/10.1001/jamanetworkopen.2020.1997.
Article PubMed PubMed Central Google Scholar
Bengtsson B, Askling J, Ludvigsson JF, Hagström H. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol 2020;55:1205–1210. https://doi.org/10.1080/00365521.2020.1820566.
Hayward KL, Johnson AL, Mckillen BJ et al. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterol 2020;7:e000485. https://doi.org/10.1136/bmjgast-2020-000485.
Article PubMed PubMed Central Google Scholar
Mapakshi S, Kramer JR, Richardson P, El-Serag HB, Kanwal F. Positive predictive value of international classification of diseases, 10th revision, codes for cirrhosis and its related complications. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2018;16:1677–1678. https://doi.org/10.1016/j.cgh.2018.01.042.
Shearer JE, Gonzalez JJ, Min T et al. Systematic review: development of a consensus code set to identify cirrhosis in electronic health records. Aliment Pharmacol Ther 2022;55:645–657. https://doi.org/10.1111/apt.16806.
Article PubMed PubMed Central Google Scholar
Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015;12:464–474. https://doi.org/10.1038/nrcardio.2015.83.
Article PubMed PubMed Central Google Scholar
Raskob GE, Angchaisuksiri P, Blanco AN et al. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost 2014;12:1580–1590. https://doi.org/10.1111/jth.12698.
Roberts LN, Hernandez-Gea V, Magnusson M et al. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: guidance from the SSC of the ISTH. J Thromb Haemost 2022;20:2237–2245. https://doi.org/10.1111/jth.15829.
Article CAS PubMed Google Scholar
Pant A, Kopec AK, Luyendyk JP. Role of the blood coagulation cascade in hepatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2018;315:G171–G176. https://doi.org/10.1152/ajpgi.00402.2017.
Article CAS PubMed PubMed Central Google Scholar
Noureddin M, Vipani A, Bresee C et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol 2018;113:1649–1659. https://doi.org/10.1038/s41395-018-0088-6.
Article PubMed PubMed Central Google Scholar
Ciavarella A, Gnocchi D, Custodero C et al. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139–150. https://doi.org/10.1016/j.thromres.2020.12.002.
Article CAS PubMed Google Scholar
Tripodi A, Lombardi R, Primignani M, La Mura V, Peyvandi F, Fracanzani AL. Hypercoagulability in patients with Nonalcoholic Fatty Liver Disease (NAFLD): causes and consequences. Biomedicines 2022;10:249. https://doi.org/10.3390/biomedicines10020249.
Article CAS PubMed PubMed Central Google Scholar
van der Windt DJ, Sud V, Zhang H et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 2018;68:1347–1360. https://doi.org/10.1002/hep.29914.
Article CAS PubMed Google Scholar
Luci C, Bourinet M, Leclère PS, Anty R, Gual P. Chronic inflammation in nonalcoholic steatohepatitis: molecular mechanisms and therapeutic strategies. Front Endocrinol 2020;11:597648. https://doi.org/10.3389/fendo.2020.597648.
Rivas G, Hummer-Bair B, Bezinover D, Kadry Z, Stine J. Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis. BMJ Open Gastroenterol 2021;8:e000683. https://doi.org/10.1136/bmjgast-2021-000683.
Article PubMed PubMed Central Google Scholar
Ogresta D, Mrzljak A, Cigrovski Berkovic M, Bilic-Curcic I, Stojsavljevic-Shapeski S, Virovic-Jukic L. Coagulation and endothelial dysfunction associated with NAFLD: current status and therapeutic implications. J Clin Transl Hepatol 2022;10:339–355. https://doi.org/10.14218/JCTH.2021.00268.
留言 (0)